Literature DB >> 856864

Solid-phase radioimmunoassay of rubella virus immunoglobulin M antibodies: comparison with sucrose density gradient centrifugation test.

O H Meurman, M K Viljanen, K Granfors.   

Abstract

The solid-phase radioimmunoassay (RIA) method developed in our laboratory for demonstrating rubella virus-specific immunoglobulin G (IgG) antibodies (Kalimo et al., 1976) was further developed for demonstrating IgM antibodies. A total of 188 serum specimens were tested. The statistical probability of obtaining a false-positive IgM result, based on determinations of 100 rubella-negative sera, was below 0.001. Nonspecific inhibitors and IgM antibodies against other viruses tested did not interfere in the assay. In 2 out of 20 (10%) serum specimens with rheumatoid factor, a false-positive IgM result was obtained. The new RIA method was compared with sucrose density gradient centrifugation, followed by hemagglutination inhibition testing of the separated immunoglobulins with respect to demonstrating IgM antibodies. In patients with acute rubella infection, IgM antibodies were demonstrated by RIA in 9 out of 20 acute-phase sera and in all 20 early-convalescent-phase sera, compared with 7 out of 20 acute-phase sera and 19 out of 20 early-convalescent-phase sera by sucrose density gradient centrifugation. The results obtained indicate that the RIA method is reliable and sensitive and suitable for routine diagnostic use.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856864      PMCID: PMC274578          DOI: 10.1128/jcm.5.3.257-262.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Antibody response to Epstein-Barr virus in infectious mononucleosis.

Authors:  J Nikoskelainen; P Hänninen
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

2.  Solid-phase radioimmunoassay of rubella virus immunoglobulin G and immunoglobulin M antibodies.

Authors:  K O Kalimo; O H Meurman; P E Halonen; B R Ziola; M K Viljanen; K Granfors; P Toivanen
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

3.  Negative complement-fixation tests with rheumatoid factor positive sera. A simple method for selective removal of rheumatoid factor.

Authors:  G Haukenes
Journal:  Ann Rheum Dis       Date:  1974-09       Impact factor: 19.103

4.  Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-IgM.

Authors:  P V Shirodaria; K B Fraser; F Stanford
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

5.  Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies.

Authors:  T Vesikari; A Vaheri
Journal:  Br Med J       Date:  1968-01-27

6.  Serum IgM and IgG responses in postnatally acquired rubella.

Authors:  J M Best; J E Banatvala; D Watson
Journal:  Lancet       Date:  1969-07-12       Impact factor: 79.321

7.  Demonstration of rubella IgM antibody by indirect fluorescent antibody staining, sucrose density gradient centrifugation and mercaptoethanol reduction.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

8.  The specificity and polyvalency of binding of a monoclonal rheumatoid factor.

Authors:  R Eisenberg
Journal:  Immunochemistry       Date:  1976-04

9.  A solid-phase radioimmunoassay for IgG and IgM antibodies against measles virus.

Authors:  P Arstila; T Vuorimaa; K Kalimo; P Halonen; M Viljanen; K Granfors; P Toivanen
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

10.  An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis.

Authors:  E C FRANKLIN; H R HOLMAN; H J MULLER-EBERHARD; H G KUNKEL
Journal:  J Exp Med       Date:  1957-05-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Laboratory diagnosis of rubella: past, present and future.

Authors:  J E Cradock-Watson
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Detection of specific immunoglobulin M antibody to rubella virus by use of an enzyme-labeled antigen.

Authors:  C Bonfanti; O Meurman; P Halonen
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

3.  Clinical evaluation of the sensitivity and specificity of a commercially available enzyme immunoassay for detection of rubella virus-specific immunoglobulin M.

Authors:  M A Chernesky; L Wyman; J B Mahony; S Castriciano; J T Unger; J W Safford; P S Metzel
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

4.  IgA antibody response in acute rubella determined by solid-phase radioimmunoassay.

Authors:  P Halonen; O Meurman; M T Matikainen; E Torfason; H Bennich
Journal:  J Hyg (Lond)       Date:  1979-08

5.  Persistent rubella-specific IgM-antibody in the cerebrospinal fluid of a child with congenital rubella.

Authors:  T Vesikari; O H Meurman; R Mäki
Journal:  Arch Dis Child       Date:  1980-01       Impact factor: 3.791

6.  The detection of rubella-specific IgM antibodies by radioimmunoassay.

Authors:  H O Kangro; J R Pattison; R B Heath
Journal:  Br J Exp Pathol       Date:  1978-12

7.  Persistence of immunoglobulin G and immunoglobulin M antibodies after postnatal rubella infection determined by solid-phase radioimmunoassay.

Authors:  O H Meurman
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

8.  Measurement of immunoglobulin M (IgM), IgG, and IgA antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: persistence of serum antibodies during disease.

Authors:  K Granfors
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

9.  [A rapid method for the determination of virus-specific IgM antibodies].

Authors:  O Goetz; P Peller; K Oettrich
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

10.  Development and evaluation of a capture enzyme-linked immunosorbent assay for determination of rubella immunoglobulin M using monoclonal antibodies.

Authors:  I Gerna; M Zannino; M G Revello; E Petruzzelli; M Dovis
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.